The Tencent and TAL Education-backed business management platform developer received the capital from IDG Capital, Hillhouse Capital, GGV Capital and Qiming Venture Partners.

The CreditEase-backed wealth management software provider was valued at $2bn after securing investment from D1 Capital Partners.

Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute, has picked up a series B co-led by SoftBank Vision Fund 2.

Motif FoodWorks, which traces its roots to MIT, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Motif’s parent agreed to a reverse merger.

The marketing platform developer is using cash from the United Internet-backed round to acquire MomentFeed, a deal that will allow Rockfish to exit.

The Johnson & Johnson, GSK and AstraZeneca-backed drug developer raised the cash in a Patient Square Capital-led round that took its total funding beyond $200m.

The CSP technology developer revealed two new funding rounds including an $83m bridge round backed by ArcelorMittal and Edison International.

GV has participated in a $41.9m series B extension for the birth control delivery service, which increased the round's size to $92.9m.

UCL Technology Fund has participated in a $145m round that will allow Apollo Therapeutics to advance assets into the clinic and open a US office.

Maryland Momentum Fund and VTC Innovation Fund have both contributed to a series A round for Veralox Therapeutics, which is focusing on diseases with unmet needs.